| Project | Research | Preclinical | Phase I | Phase II | Phase III | Licensed |
| Immune Globulin Subcutaneous (Human) 10% Primary immunodeficiency (PI) | ||||||
| Immune Globulin Subcutaneous (Human) 10% with Recombinant Human Hyaluronidase (Phase II & III) Primary immunodeficiency (PI) | ||||||
| Immune Globulin Intravenous (Human) 10% Multifocal motor neuropathy | ||||||
| Immune Globulin Intravenous (Human) 10% Mild to moderate alzheimer’s disease | ||||||
| High Concentration Immune Globulin Subcutaneous (Human) (Preclinical) | ||||||
| High Concentration Immune Globulin Subcutaneous (Human) with Recombinant Human Hyaluronidase (Preclinical) | ||||||
Baxter BioScience Grants Program
For more information on subcutaneous injection, please click here to view the video.
